Stock & Company Details
Inhibrx Inc $INBX
Price:
N/A
N/A
15M
$1.1B
52 Week High:
N/A
10 Day Average Volume:
N/A
-8.78
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
INBX technical indicators
Latest Inhibrx Inc (INBX) indicator readings as of 2026-10-29.
INBX's 14-day RSI is 32.2, in neutral territory. At $73.65 it is trading 20.1% below its 200-day moving average of $92.16, and below its 50-day average of $102.89. Price sits below the lower Bollinger Band ($77.41 to $104.01). ADX reads 17.4, indicating a range-bound market rather than a trend.
Overview
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates. The company has four programs in clinical trials, of which three of the programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency.
Finance Bot
Ask your questions
Start by typing a question below.
